Intranasal administration of GRP78 protein (HSPA5) counteracts the neurodegeneration in the locus coeruleus in a model of chronic sleep restriction in rats

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Chronic sleep restriction (sleep less than 6 hours per day) due to the workload and a decrease in sleep quality is an endemic disease in modern society. Chronic sleep deprivation causes serious neuropsychiatric disorders associated with irreversible neurodegenerative changes in the brain. The search for pharmacological agents that can reduce the risk of neurodegeneration as a result of chronic sleep loss is an urgent task issue for biomedicine. Intranasal administration of glucose-regulated 78 kDa heat shock protein (GRP78) has a neuroprotective effect in a rat model of Parkinson´s disease. The neuroprotective potential of intranasally administered GRP78 in chronic sleep deprivation has not been previously studied. The aim of the study is to find out whether preventive intranasal administration of GRP78 is able to weaken and/or stop the process of neurodegeneration in the locus coeruleus in the model of chronic sleep restriction (SR) in rats. The study was conducted on 6 months old male Wistar rats. For sleep deprivation, a validated method of a swinging platform was used in the mode: 3 hours of sleep deprivation and 1 hour of rest continuously for 5 days. Recombinant human protein GRP78 was administered intranasally two days before the start of SR and during 5 days of SR. Cellular and molecular changes in the locus coeruleus during SR and during the administration of GRP78 were studied using immunohistochemistry and Western blotting. It was shown that chronic SR leads to the degeneration of 30% of noradrenergic neurons in the locus coeruleus, that was associated with an increase in the levels of activated caspases-3 and 9. This indicates the development of apoptosis along the mitochondrial pathway. No signs of reactive microgliosis were found in the model of chronic SR in rats. We have demonstrated that intranasally administered GRP78 penetrates and accumulates in the neurons of the locus coeruleus, GRP78 counteracts the death of neurons along the path of apoptosis. The data obtained allows to consider GRP78 as a potential neuroprotective agent for the prevention of pathological consequences of chronic sleep deprivation.

Full Text

Restricted Access

About the authors

M. B. Pazi

Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences

Author for correspondence.
Email: pazimariia@gmail.com
Russian Federation, St. Petersburg

I. V. Ekimova

Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences

Email: pazimariia@gmail.com
Russian Federation, St. Petersburg

References

  1. Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K (2015) The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol 14: 547–558. https://doi.org/10.1016/S1474–4422(15)00021–6
  2. Strygin KN, Poluektov MG (2017) INSOMNIA. Medical Council 52–58. https://doi.org/10.21518/2079–701X-2017–0–52–58
  3. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M (2008) Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 04: 487–504. https://doi.org/10.5664/jcsm.27286
  4. Shan W, Peng X, Tan W, Zhou Z, Xie H, Wang S (2024) Prevalence of insomnia and associations with depression, anxiety among adults in guangdong, China: A large-scale cross-sectional study. Sleep Med 115: 39–47. https://doi.org/10.1016/j.sleep.2024.01.023
  5. Ahn E, Baek Y, Park J-E, Lee S, Jin H-J (2024) Elevated prevalence and treatment of sleep disorders from 2011 to 2020: a nationwide population-based retrospective cohort study in Korea. BMJ Open 14: e075809. https://doi.org/10.1136/bmjopen-2023–075809
  6. Hisler G, Muranovic D, Krizan Z (2019) Changes in sleep difficulties among the U.S. population from 2013 to 2017: results from the National Health Interview Survey. Sleep Health 5: 615–620. https://doi.org/10.1016/j.sleh.2019.08.008
  7. Norell-Clarke A, Hagquist C (2017) Changes in sleep habits between 1985 and 2013 among children and adolescents in Sweden. Scand J Public Health 45: 869–877. https://doi.org/10.1177/1403494817732269
  8. Costa A, Pereira T (2019) The effects of sleep deprivation on cognitive performance. Eur J Public Health 29: ckz034.096. https://doi.org/10.1093/eurpub/ckz034.096
  9. Al-Abri M (2015) Sleep deprivation and depression: A bi-directional association. Sultan Qaboos Univ Med J 15: e4-e6.
  10. Rosen I, Gimotty P, Shea J, Bellini L (2006) Evolution of sleep quantity, sleep deprivation, mood disturbances, empathy, and burnout among interns. Acad Med 81: 82–85. https://doi.org/10.1097/00001888–200601000–00020
  11. Belenky G, Wesensten N, Thorne D, Thomas M, Sing H, Redmond D, Russo M, Balkin T (2003) Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose‐response study. J Sleep Res 12: 1–12. https://doi.org/10.1046/j.1365–2869.2003.00337.x
  12. Pejovic S, Basta M, Vgontzas A, Kritikou I, Shaffer M, Tsaoussoglou M, Stiffler D, Stefanakis Z, Bixler E, Chrousos G (2013) Effects of recovery sleep after one work week of mild sleep restriction on interleukin-6 and cortisol secretion and daytime sleepiness and performance. Am J Physiol Endocrinol Metab 305: E890-E896. https://doi.org/10.1152/ajpendo.00301.2013
  13. Van Dongen H, Maislin G, Mullington J, Dinges D (2003) The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 26: 117–126. https://doi.org/10.1093/sleep/26.2.117
  14. Lutsey P, Misialek J, Mosley T, Gottesman R, Punjabi N, Shahar E, MacLehose R, Ogilvie R, Knopman D, Alonso A (2018) Sleep characteristics and risk of dementia and Alzheimer’s disease: The atherosclerosis risk in communities study. Alzheimers Dement 14: 157–166. https://doi.org/10.1016/j.jalz.2017.06.2269
  15. Pase M, Himali J, Grima N, Beiser A, Satizabal C, Aparicio H, Thomas R, Gottlieb D, Auerbach S, Seshadri S (2017) Sleep architecture and the risk of incident dementia in the community. Neurology 89: 1244–1250. https://doi.org/10.1212/WNL.0000000000004373
  16. Owen J, Zhu Y, Fenik P, Zhan G, Bell P, Liu C, Veasey S (2021) Late-in-life neurodegeneration after chronic sleep loss in young adult mice. Sleep 44(8): zsab057. https://doi.org/10.1093/sleep/zsab057
  17. Zhu Y, Fenik P, Zhan G, Somach R, Xin R, Veasey S (2016) Intermittent short sleep results in lasting sleep wake disturbances and degeneration of locus coeruleus and orexinergic neurons. Sleep 39: 1601–1611. https://doi.org/10.5665/sleep.6030
  18. Zhang J, Zhu Y, Zhan G, Fenik P, Panossian L, Wang M, Reid S, Lai D, Davis J, Baur J, Veasey S (2014) Extended wakefulness: compromised metabolics in and degeneration of locus coeruleus neurons. J Neurosci 34: 4418–4431. https://doi.org/10.1523/JNEUROSCI.5025–12.2014
  19. Aston-Jones G, Bloom F (1981) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1: 876–886. https://doi.org/10.1523/JNEUROSCI.01–08–00876.1981
  20. Benington J, Craig Heller H (1995) Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol 45: 347–360. https://doi.org/10.1016/0301–0082(94)00057-O
  21. Costa C, Manaa W, Duplan E, Checler F (2020) The endoplasmic reticulum stress/unfolded protein response and their contributions to Parkinson’s disease physiopathology. Cells 9: 2495. https://doi.org/10.3390/cells9112495
  22. Naidoo N, Giang W, Galante R, Pack A (2005) Sleep deprivation induces the unfolded protein response in mouse cerebral cortex. J Neurochem 92: 1150–1157. https://doi.org/10.1111/j.1471–4159.2004.02952.x
  23. Voronin MV, Abramova EV, Verbovaya ER, Vakhitova YV, Seredenin SB (2023) Chaperone-dependent mechanisms as a pharmacological target for neuroprotection. Int J Mol Sci 24: 823. https://doi.org/10.3390/ijms24010823
  24. Gorbatyuk M, Gorbatyuk O (2013) The molecular chaperone GRP78/BiP as a therapeutic target for neurodegenerative disorders: A mini review. J Genet Syndr Gene Ther 4. https://doi.org/10.4172/2157–7412.1000128
  25. Pazi M, Belan D, Komarova E, Ekimova I (2024) Intranasal administration of GRP78 protein (HSPA5) confers neuroprotection in a lactacystin-induced rat model of parkinson’s disease. Int J Mol Sci 25: 3951. https://doi.org/10.3390/ijms25073951
  26. Guzeev MA, Kurmazov NS, Simonova VV, Pastukhov YuF, Ekimova IV (2021) Modeling of chronic sleep restriction for translational studies. SS Korsakov J Neurol Psychiatr 121(4–2): 6–13. https://doi.org/10.17116/jnevro20211214026
  27. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. 6th ed. Elsevier. Amsterdam.
  28. Manchanda S, Singh H, Kaur T, Kaur G (2018) Low-grade neuroinflammation due to chronic sleep deprivation results in anxiety and learning and memory impairments. Mol Cell Biochem 449: 63–72. https://doi.org/10.1007/s11010–018–3343–7
  29. Hurtado-Alvarado G, Domínguez-Salazar E, Pavon L, Velázquez-Moctezuma J, Gómez-González B (2016) Blood-brain barrier disruption induced by chronic sleep loss: Low-grade inflammation may be the link. J Immunol Res 2016: 1–15. https://doi.org/10.1155/2016/4576012
  30. Deurveilher S, Semba K (2019) Physiological and neurobehavioral consequences of chronic sleep sestriction in rodent models. Handbook Sleep Res 557–567. https://doi.org/10.1016/B978–0–12–813743–7.00037–2
  31. Deurveilher S, Rusak B, Semba K (2012) Time-of-day modulation of homeostatic and allostatic sleep responses to chronic sleep restriction in rats. Am J Physiol Regul Integr Comp Physiol 302(12): R1411-R1425. https://doi.org/10.1152/ajpregu.00678.2011
  32. Takemoto H, Yoshimori T, Yamamoto A, Miyata Y, Yahara I, Inoue K, Tashiro Y (1992) Heavy chain binding protein (BiP/GRP78) and endoplasmin are exported from the endoplasmic reticulum in rat exocrine pancreatic cells, similar to protein disulfide-isomerase. Arch Biochem Biophys 296: 129–136. https://doi.org/10.1016/0003–9861(92)90554-A
  33. Baek J-H, Mamula D, Tingstam B, Pereira M, He Y, Svenningsson P (2019) GRP78 level is altered in the brain, but not in plasma or cerebrospinal fluid in Parkinson’s disease patients. Front Neurosci 13: 697. https://doi.org/10.3389/fnins.2019.00697
  34. Casas C (2017) GRP78 at the centre of the stage in cancer and neuroprotection. Front Neurosci 11: 177. https://doi.org/10.3389/fnins.2017.00177
  35. Shields A, Thompson S, Panayi G, Corrigall V (2012) Pro-resolution immunological networks: binding immunoglobulin protein and other resolution-associated molecular patterns. Rheumatology (Oxford) 51: 780–788. https://doi.org/10.1093/rheumatology/ker412
  36. Eggleton P, De Alba J, Weinreich M, Calias P, Foulkes R, Corrigall V (2023) The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases. J Cell Mol Med 27: 322–339. https://doi.org/10.1111/jcmm.17669
  37. Zhu Y, Fenik P, Zhan G, Mazza E, Kelz M, Aston-Jones G, Veasey S (2007) Selective loss of catecholaminergic wake–active neurons in a murine sleep apnea model. J Neurosci 27: 10060–10071. https://doi.org/10.1523/JNEUROSCI.0857–07.2007
  38. Somarajan B, Khanday M, Mallick B (2016) Rapid eye movement sleep deprivation induces neuronal apoptosis by noradrenaline acting on alpha1 adrenoceptor and by triggering mitochondrial intrinsic pathway. Front Neurol 7: 25. https://doi.org/10.3389/fneur.2016.00025
  39. Leiva-Rodríguez T, Romeo-Guitart D, Herrando-Grabulosa M, Muñoz-Guardiola P, Polo M, Bañuls C, Petegnief V, Bosch A, Lizcano J, Apostolova N, Forés J, Casas C (2021) GRP78 Overexpression triggers PINK1-IP3R-mediated neuroprotective mitophagy. Biomedicines 9: 1039. https://doi.org/10.3390/biomedicines9081039
  40. Bellesi M, de Vivo L, Chini M, Gilli F, Tononi G, Cirelli C (2017) Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex. J Neurosci 37: 5263–5273. https://doi.org/10.1523/JNEUROSCI.3981–16.2017
  41. Wadhwa M, Kumari P, Chauhan G, Roy K, Alam S, Kishore K, Ray K, Panjwani U (2017) Sleep deprivation induces spatial memory impairment by altered hippocampus neuroinflammatory responses and glial cells activation in rats. J Neuroimmunol 312: 38–48. https://doi.org/10.1016/j.jneuroim.2017.09.003
  42. Hall S, Deurveilher S, Robertson G, Semba K (2020) Homeostatic state of microglia in a rat model of chronic sleep restriction. Sleep 43(11): zsaa108. https://doi.org/10.1093/sleep/zsaa108
  43. Hou J, Shen Q, Wan X, Zhao B, Wu Y, Xia Z (2019) REM sleep deprivation-induced circadian clock gene abnormalities participate in hippocampal-dependent memory impairment by enhancing inflammation in rats undergoing sevoflurane inhalation. Behav Brain Res 364: 167–176. https://doi.org/10.1016/j.bbr.2019.01.038
  44. Xie L, Kang H, Xu Q, Chen M, Liao Y, Thiyagarajan M, O’Donnell J, Christensen D, Nicholson C, Iliff J, Takano T, Deane R, Nedergaard M (2013) Sleep drives metabolite clearance from the adult brain. Science 342: 373–377. https://doi.org/10.1126/science.1241224
  45. Lapshina KV, Ekimova IV (2024) Aquaporin-4 and Parkinson’s Disease. Int J Mol Sci 25: 1672. https://doi.org/10.3390/ijms25031672
  46. Shokri-Kojori E, Wang G-J, Wiers C, Demiral S, Guo M, Kim S, Lindgren E, Ramirez V, Zehra A, Freeman C, Miller G, Manza P, Srivastava T, De Santi S, Tomasi D, Benveniste H, Volkow N (2018) β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci U S A 115: 4483–4488. https://doi.org/10.1073/pnas.1721694115
  47. Ju Y-ES, Ooms S, Sutphen C, Macauley S, Zangrilli M, Jerome G, Fagan A, Mignot E, Zempel J, Claassen J, Holtzman D (2017) Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels. Brain 140: 2104–2111. https://doi.org/10.1093/brain/awx148
  48. Lapshina KV, Guzeev MA, Ekimova IV (2016) Glucose-regulated protein Grp78 affects characteristics of sleep and thermoregulation in rats. J Evol Biochem Physiol 52: 161–167. https://doi.org/10.1134/S002209301602006X
  49. Naidoo N, Casiano V, Cater J, Zimmerman J, Pack A (2007) A role for the molecular chaperone protein BiP/GRP78 in drosophila sleep homeostasis. Sleep 30: 557–565. https://doi.org/10.1093/sleep/30.5.557

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Experimental scheme. Adaptation (7 days) – animal adaptation for 7 days. Chronic sleep restriction (SR) – chronic sleep restriction. Day 1–5 – 1–5 days of sleep restriction. IHC – immunohistochemistry, taking brain biomaterial for immunohistochemical analysis. WB – western-blot, taking brain biomaterial for western blotting analysis.

Download (55KB)
3. Fig. 2. Exogenous GRP78 administered intranasally accumulates in locus coeruleus neurons in rats under control conditions. (a) Representative photomicrographs of the locus coeruleus. (b) Optical density of locus coeruleus neurons. Data are presented as mean ± SEM. Control – control animals treated with GRP78 vehicle, sterile pyrogen-free phosphate buffer pH 7.4 (PBS) (n = 3); Grp78 – animals treated with GRP78 intranasally (n = 3). Differences between groups according to Student's t-test and are indicated as *p ≤ 0.05 compared to the control group.

Download (164KB)
4. Fig. 3. Intranasal administration of exogenous GRP78 prevents degeneration of noradrenergic neurons of the locus coeruleus in the chronic sleep restriction model. (a, c) – representative photomicrographs of the locus coeruleus, (b) – number of TH-positive neurons in the locus coeruleus, (d) – number of Nissl-stained neurons in the locus coeruleus. Data are presented as mean ± SEM. Control – control animals (n = 5), (Grp78) – administration of Grp78 under control conditions (n ​​= 3), Sleep restriction (SR) – sleep restriction for 5 days (n = 5), SR+Grp78 – administration of Grp78 in the chronic sleep restriction model (n = 5). Differences between groups according to one-way ANOVA followed by Tukey post-hoc are indicated as: *** p < 0.001 compared to the control group; ## p < 0.01, ### p < 0.001 compared with sleep restriction effect.

Download (482KB)
5. Fig. 4. Intranasal administration of exogenous GRP78 prevents apoptosis in the chronic sleep restriction model. (a) – cleaved caspase-9 content, (b) – cleaved caspase-3 content, (c) – representative immunoblots. Data are presented as mean ± SEM. Control – control animals (n = 5), SR – sleep restriction, sleep restriction for 5 days (n = 5), SR+Grp78 – administration of Grp78 in the chronic sleep restriction model (n = 5). Differences between groups according to one-way ANOVA followed by Tukey post-hoc are indicated as: ** p < 0.01 compared with the control group; # p < 0.05 compared with the effect of sleep restriction.

Download (126KB)

Copyright (c) 2024 Russian Academy of Sciences